About STRAND THERAPEUTICS INC.
Strand is a clinical-stage biotechnology company developing breakthrough mRNA therapeutics for cancers and autoimmune diseases, focusing on solving key challenges in genetic medicine through innovative delivery systems.
Development of mRNA therapeutics for cancers and autoimmune diseasesEngineering lipid nanoparticles (LNPs) for high on-target tissue delivery throughout the bodyPioneering microRNA-sensing technology for encrypted mRNA to ensure safety and selectivityExpanding the mRNA toolbox with potent, durable self-replicating and circular RNA
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| SENTINOX (STX)-005: A NEXT-GENERATION THERAPY FOR AUTOIMMUNE DISEASE TO SUSTAIN FORCE READINESS | Department of Defense | $1.2M |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to STRAND THERAPEUTICS INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.